Last reviewed · How we verify

NCT03646422

AEDV Registry of Primary Cutaneous Lymphoma

Status unknown Last updated 31 March 2022
What this trial tests

trial testing Registry of patients (exposure is Cutaneous Lymphoma) in Lymphoma, T-Cell, Cutaneous in 2,000 participants. Status unknown.

Timeline
1 September 2016
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorFundación Academia Española de Dermatología
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,000
Start date1 September 2016
Primary completion1 January 2025
Estimated completion1 January 2025
Sites14 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundación Academia Española de Dermatología

Who can join

Eligibility, any sex, with Lymphoma, T-Cell, Cutaneous or Lymphoma, B-Cell, Marginal Zone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Registry of patients with Primary Cutaneous Lymphoma seen at participating centers in Spain. The registry will identify patients with this disease and includes information about stage, diagnostic and therapeutic interventions and willingness to participate in further studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lymphoma, T-Cell, Cutaneous

Currently open trials in the same condition.

Other Fundación Academia Española de Dermatología trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03646422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing